SCOTTSDALE, AZ - August 8, 2023 — NeoLight, a leading medical device company specialized in neonatal care, is thrilled to announce a groundbreaking partnership with Florida State University (FSU) to extend the application of P.A.L. technology, aiming to bring the benefits of this innovative system to a larger number of premature infants. This collaboration underscores NeoLight's relentless focus on innovative solutions that improve newborn health outcomes.
The P.A.L. system is a unique therapeutic approach that emphasizes the development of non-nutritive sucking for premature infants. By providing positive feedback, the system encourages and strengthens the baby's non-nutritive sucking behavior, a critical aspect of infant development.
Jayne M. Standley, Ph.D., MT-BC, NICU-MT, a Robert O. Lawton Distinguished Professor at Florida State University, said, "The National Institute for Infant and Child Medical Music Therapy is excited about this new entrepreneurial partnership with NeoLight, a nationally recognized leader in newborn healthcare technology. We will provide research and clinical expertise promoting innovative uses of music for improved healthcare for premature infants."
Established at Florida State University in 2005, the National Institute for Infant & Child Medical Music Therapy provides an international focus on research, evidence-based clinical practice, and professional training in the use of music therapy to enhance medical treatment of infants and children.
On faculty at FSU since 1976, Standley is recognized throughout the United States as the foremost authority on medical music therapy.
NeoLight continues to emphasize the importance of innovation in neonatal care. By partnering with esteemed institutions like FSU, NeoLight aims to continue being at the forefront of new technologies and therapies that make a difference in the lives of the youngest patients and their families.
About Florida State University
Florida State University is a preeminent research university dedicated to advancing the next generation of scholars, researchers, and professionals. Through its National Institute for Infant and Child Medical Music Therapy, FSU has been a pioneer in advancing healthcare outcomes for newborns and young children.
###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.
